Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
480
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Journal of Research in Ayurvedic Sciences
2021
April - June
;
5
(2)
:87-94
A multicenter clinical trial on the anti-diabetic efficacy and safety profile of Saptavimshatika Guggulu and Haridra Churna in the management of type 2 diabetes mellitus
Avinash K Jain (1)
,
Avinash K Jain (1)
,
Babita Yadav (1)
,
Babita Yadav (1)
,
Shruti Khanduri (2)
,
Shruti Khanduri (2)
,
Sarada Ota (1)
,
Sarada Ota (1)
,
Rakesh Rana (2)
,
Rakesh Rana (2)
,
Richa Singhal (1)
,
Richa Singhal (1)
,
Madan M Padhi (1)
,
Madan M Padhi (1)
,
Kartar S Dhiman (2)
,
Kartar S Dhiman (2)
,
Surinder K Sharma (3)
,
Surinder K Sharma (3)
,
Om R Sharma (3)
,
Om R Sharma (3)
,
Dipsundar Sahu (4)
,
Dipsundar Sahu (4)
,
Vinod B Kumawat (5)
,
Vinod B Kumawat (5)
,
Pradeep Dua (6)
,
Pradeep Dua (6)
,
Gurucharan Bhuyan (7)
,
Gurucharan Bhuyan (7)
,
Bharti Gupta (8)
,
Bharti Gupta (8)
1. Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, India 2. Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, India 3. Regional Ayurveda Research Institute for Nutritional Disorders, Mandi, Himachal Pradesh, India 4. Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India 5. Regional Ayurveda Research Institute for Drug Development, Gwalior, Madhya Pradesh, India 6. Bureau of Indian Standard Hqrs., New Delhi, India 7. Central Ayurveda Research Institute for Hepatobiliary Disorders, Bhubaneswar, Odisha, India 8. Central Ayurveda Research Institute for Cardiovascular Disorders, New Delhi, India
Abstract
BACKGROUND: Madhumeha (diabetes mellitus [DM]) disease is one of the very few diseases, which has been found in the history and culture of India and across the globe. Since ages, even in the twenty-first century, this disease is a cause of concern to the world due to its morbidity and long-term complications. Traditional medicines are still found to be very useful in the improvement of quality of life (QOL) of the patients with Madhumeha. Ayurvedic formulations are found to be useful in the management of type II DM and in promoting health. OBJECTIVE: Saptavimshatika Guggulu (SG) and Haridra Churna (HC) were evaluated to assess their clinical effectiveness in the management of type 2 diabetes. A secondary objective was to assess the changes in the QOL of the patients with type 2 DM and the clinical safety of SG and HC. MATERIALS AND METHODS: This multicenter clinical study was critically evaluated to assay the clinical efficacy and safety profile of ayurvedic formulations, SG 500?g two tablets two times after food and HC 3?g with luke-warm water after food two times daily for 12 weeks in 146 participants, diagnosed with NIIDM, enrolled as per the selection criteria. RESULTS: The results were of highly significant in the regulation of FBS (BT-167.44?mg/dL, AT-152.83?mg/dL) and PPBS (BT-261.74?mg/dL, AT-240.59?mg/dL). Statistically highly significant result was found in the improvement of Diabetes Symptoms Questionnaire and SF-36 health survey score; no ADR or any complications were noted. CONCLUSION: SG and HC used on the subjects of type 2 DM (Madhumeha) are clinically effective, safe, and tolerable. Keywords: Haridra Churna, Madhumeha, Saptavimshatika Guggulu, type 2 diabetes mellitus
DHARA ID:
D060637
Link To Full Paper
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi